Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Justin Holdings, Inc. was a biotechnology holding company primarily known for its joint venture with Vyta Corp (formerly NanoPierce Technologies) to form BioAgra, LLC. The company focused on the development and commercialization of AgraStim, a purified yeast beta-1,3/1,6-D glucan product derived from spent brewer's and distillery yeast. AgraStim was marketed as an all-natural, organic feed supplement designed to replace growth-promoting antibiotics in the poultry, swine, and aquaculture industries by enhancing the immune systems of animals. While the company was active in the mid-to-late 2000s, its primary operations through BioAgra have since ceased following legal and financial challenges involving its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Justin Holdings.